James Lovgren (@JamesLovgren) header
James Lovgren (@JamesLovgren) profile picture

CEO & Co-Founder @AspiroTx | #LifeScience Board Director | #Biotech Exec | Revolutionizing treatment for #COPD & #Asthma | World Traveler | @Giants Fan

Global
Joined February 2011
Photo by James Lovgren (@JamesLovgren)Photo by James Lovgren (@JamesLovgren)Photo by James Lovgren (@JamesLovgren)Photo by James Lovgren (@JamesLovgren)Photo by James Lovgren (@JamesLovgren)Photo by James Lovgren (@JamesLovgren)Photo by James Lovgren (@JamesLovgren)Photo by James Lovgren (@JamesLovgren)Photo by James Lovgren (@JamesLovgren)Photo by James Lovgren (@JamesLovgren)
Let’s connect at @jpmorgan Week 2027! I’m looking forward to returning to San Francisco, January 11 to 14, and connecting with investors, strategic partners, and colleagues across the life sciences community. #JPMWEEK27 #JPM2027 #JPMWeek #biopartnering app.sosha.ai/s/qwBPhFqd
1
1
1
122
Why is CC16 attracting growing interest in respiratory research? Looking forward to new findings being presented next week at #ERSCongress examining the relationship between CC16 and respiratory health in young adults. #RespiratoryMedicine #Asthma #COPD
🤖 Made with AI
1
2
134
Looking forward to participating in #RESISanDiego and connecting with investors & strategic partners. @AspiroTx is developing an inhaled peptidomimetic therapy that mimics the protective power of CC16. Attending #RESISanDiego, let’s connect. #biotech #COPD #ASthama @LSciNation
1
1
79
On #WorldAsthmaDay, we recognize the need to go beyond symptom control. Patients need therapies that address the disease, not just flare ups. @AspiroTx We are working toward restoring lung function & preventing disease progression. #AsthmaAwareness #RespiratoryHealth #Biotech
1
1
42
Heading to @atscommunity Respiratory Innovation Summit next month in Orlando. We will be presenting new data showing a key step forward for our program, with a stable aerosol formulation enabling consistent delivery to the lung. #ATS2026 #RIS2026 #Biotech
3
3
848
Excited to attend Investival Showcase March 10–11 @AspiroTx is developing an inhaled, disease-modifying therapy for asthma and COPD by mimicking the protective biology of CC16. Meeting with investors to discuss early-stage therapeutic development. #InvestivalUSA #Biotech
1
1
121
Joining ABD Capital Connect at #JPMWeek2026 to share Aspiro’s progress in respiratory innovation. In SF? Let’s connect. @AspiroTx #copd #asthma #Biotech
1
1
65
Today we recognize the millions living with COPD, a leading cause of morbidity & mortality. Up to 70% of adults with COPD remain undiagnosed We’re developing a therapy to reduce inflammation, strengthen epithelial defenses, and modify disease progression💙 #WorldCOPDDay #COPD
1
1
41
🌍 World Lung Day 🌍 We stand with patients, caregivers, & all working toward healthier breathing for all. 💙 Aspiro Therapeutics is developing an inhaled CC16 therapy to reduce inflammation, strengthen defenses, and change the course of disease. #WorldLungDay #COPD #Asthma
1
1
80
Early COPD is getting long overdue attention. This CNN piece highlights how lung damage can begin decades before diagnosis. At Aspiro, we are developing an inhaled CC16-based therapy targeting these early pathways. @katiahetter @CNN 🔗 edition.cnn.com/2025/08/28/h…
1
3
64
Excited to join #RESIBoston next month for 3 days of hybrid partnering across biotech and diagnostics. I’ll be in Boston all week for Biotech Week (Sept 16–19). Let’s connect if you’re focused on respiratory innovation or early-stage biotech. resiconference.com/resi-bost…
1
30
We’re proud to share that Dr. Stefano Guerra and @Dr_Ledford Ledford, two of our co-founders, are contributing to NIH-funded research on CC16 and early COPD. Dr. Guerra leads the $3.8M NIAID study with Dr. Ledford as co-investigator. #COPD #NIH #Biotech research.arizona.edu/news/38…
2
4
70
We’re excited to welcome @MattBritz and Dr. Anne Dixon as advisors to Aspiro! Matt brings deep biotech leadership, and Anne is a leading pulmonary expert. Their guidance will support our CC16-based approach for asthma and COPD. 🔗 buff.ly/y43uYui #biotech #asthma #COPD
1
4
204
Excited to share that Aspiro Therapeutics has been selected to present at the #BIO2025 Startup Stadium in Boston! @JamesLovgren will present our inhaled therapy inspired by CC16, Join us Thurs, June 19. Let’s connect. #StartupStadium #Biotech #COPD #Asthma #RespiratoryHealth
1
2
76
We’re just days away! Aspiro CEO @JamesLovgren will present at #RIS2025 this Saturday, May 17 at 2:00 PM PT. Join us as we share our CC16-driven approach to transforming care for COPD & asthma. 🌬️ 🔗 Agenda: conference.thoracic.org/prog… #COPD #Asthma #Biotech #ATS2025
1
2
109
On #WorldAsthmaDay, we stand with millions living with asthma—and the urgent need for better care. At Aspiro, we’re developing a therapy inspired by the body’s own defenses to restore lung function and prevent progression. #asthma #CC16 #biotechforgood #WorldAsthmaDay2025
2
2
52
Looking forward to presenting Aspiro’s innovative, CC16-driven science at the 2025 Respiratory Innovation Summit next month!
Excited to share that Aspiro CEO @JamesLovgren will present at #RIS2025 on Saturday, May 17 at 2:00 PM PT in San Francisco! We’re honored to be a Showcase Company advancing new solutions in #respiratoryhealth. 🌬️ Agenda: conference.thoracic.org/prog… #ATS2025 #COPD #Asthma #Biotech
38
Excited to share that Aspiro CEO @JamesLovgren will present at #RIS2025 on Saturday, May 17 at 2:00 PM PT in San Francisco! We’re honored to be a Showcase Company advancing new solutions in #respiratoryhealth. 🌬️ Agenda: conference.thoracic.org/prog… #ATS2025 #COPD #Asthma #Biotech
1
1
2
128
James Lovgren retweeted
Biotech Venture Creation: The Benefits Of Scarcity. The equity markets have collapsed in 2025, the IPO window is closed, the FDA is in turmoil, the NIH is being gutted… and it’s a great time to start new biotech companies. lifescivc.com/2025/04/biotec…
14
32
5
165
26,305